Kalaris Therapeutics Stock (NASDAQ:KLRS)
Previous Close
$2.90
52W Range
$2.65 - $24.15
50D Avg
$4.88
200D Avg
$11.24
Market Cap
$51.62M
Avg Vol (3M)
$47.76K
Beta
-
Div Yield
-
KLRS Company Profile
Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.